Showing results (211-220 of 366) with videos related to
Sort By:
Pageof 37
The American Journal of Clinical Nutrition|October 9, 2007
The 2005 Dietary Guidelines for Americans and risk of the metabolic syndromeJeanene J Fogli-Cawley, Johanna T Dwyer, Edward Saltzman, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Synthesis of Novel 3,5-Disubstituted-2-oxindole Derivatives As Antitumor Agents against Human Nonsmall Cell Lung CancerGiulia Nesi, Simona Sestito, Valentina Mey, et al.Postgraduate Medicine|January 24, 2020
Real-world management of hyperkalemia with patiromer among United States VeteransCsaba P Kovesdy, Elvira O Gosmanova, Steven D Woods, et al.Kidney International Reports|February 19, 2019
Real-World Evaluation of Patiromer for the Treatment of Hyperkalemia in Hemodialysis PatientsCsaba P Kovesdy, Christopher G Rowan, Ansgar Conrad, et al.British Journal of Haematology|September 6, 2000
In vitro anti-tumour activity of anti-CD80 and anti-CD86 immunotoxins containing type 1 ribosome-inactivating proteinsA Bolognesi, L Polito, P L Tazzari, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 5, 2018
Autophosphorylated CaMKII Facilitates Spike Propagation in Rat Optic NerveGloria J Partida, Anna Fasoli, Alex Fogli Iseppe, et al.Blut|May 1, 1990
Sensitivity of chronic myeloid leukemia hemopoietic progenitors to PTT-119 in combination with human recombinant interferon alpha and gammaG Visani, R M Lemoli, P Tosi, et al.Haematologica|September 1, 1994
Persistence of non clonal hematopoietic progenitor cells in blastic phase chronic myelogenous leukemia (CML). Working Party on Severe Aplastic Anemia (WPSAA) of the European Group of Bone Marrow Transplantation (EBMT)G Martinelli, R M Lemoli, P Farabegoli, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 11, 2006
Peptidomics and proteomics studies of transformed lymphocytes from patients mutated for the eukaryotic initiation factor 2BAnne Fogli, Claire Malinverni, Lynne Thadikkaran, et al.ESMO Open|August 22, 2020
erbB in NSCLC as a molecular target: current evidences and future directionsMarzia Del Re, Federico Cucchiara, Iacopo Petrini, et al.Pageof 37